Clinical trials: Tobacco Abstinence Syndrome
Tobacco Abstinence Syndrome
Intranasal Insulin for Weight Management During Smoking Cessation
This FDA-approved (IND# 120700) study will evaluate efficacy of intranasal insulin in reducing snack intake and reducing postprandial free fatty acid levels in abstinent smokers.
- Trial name
- NCT02028871
- Testing
- Intranasal Insulin
- Where
- 2 sites in United States
- Volunteers
- 26 people, healthy volunteers welcome
- Sponsor
- Ajna Hamidovic
Tobacco Use Cessation
Mobile Media-Rich Interactive Guideline System (MMRIGS) Pilot Study
The goal of this research study is to learn about 2 different interactive methods that are designed to help people with HIV/AIDS stop smoking.
- Trial name
- NCT02302859
- Testing
- Nicotine Patch, Questionnaires, Pamphlet
- Where
- United States
- Volunteers
- 8 people, healthy volunteers welcome
- Sponsor
- M.D. Anderson Cancer Center
Tobacco Abstinence Syndrome
Efficacy Study of Intranasal Insulin to Treat Tobacco Abstinence Syndrome
This study will evaluate safety and efficacy of intranasal insulin in abstinent smokers. Groups' (placebo vs. insulin) cognitive function and stress response will be compared.
- Trial name
- NCT01781234
- Testing
- Intranasal Insulin
- Where
- United States
- Volunteers
- 51 people, healthy volunteers welcome
- Sponsor
- Ajna Hamidovic